Mojirade James - 04 Mar 2025 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, General Counsel
Signature
/s/ John Hurley, as attorney-in-fact for Mojirade James
Issuer symbol
AVNS
Transactions as of
04 Mar 2025
Transactions value $
-$71,172
Form type
4
Filing time
06 Mar 2025, 14:25:56 UTC
Previous filing
23 Jul 2024
Next filing
10 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Options Exercise $0 +8.04K +11.43% $0.00 78.4K 04 Mar 2025 Direct F1
transaction AVNS Common Stock Tax liability -$39.9K -2.64K -3.36% $15.13 75.7K 04 Mar 2025 Direct F2
transaction AVNS Common Stock Tax liability -$31.3K -2.07K -2.73% $15.13 73.6K 04 Mar 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 8,039 PRSUs which vested on March 4, 2025.
F3 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 6,880 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock.